Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(OP:
RADCQ
)
0.0250
-0.0250 (-50.00%)
Streaming Delayed Price
Updated: 3:36 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about RADCQ
Walgreens Mulls Bond Sale As JPMorgan Gauges Investor Appetite: Report
July 25, 2024
JP Morgan Chase is reportedly gauging investor interest in a possible issuance of high-yield bonds by Walgreens Boots Alliance, aimed at managing the drug-store chain's recently downgraded near-term...
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
3 Cybersecurity Stocks That Could Be Multibaggers in the Making: July Edition
July 17, 2024
When it comes to cyber threats, we’re sitting ducks, which creates more opportunity for leading cybersecurity stocks.
Via
InvestorPlace
CVS, Rite Aid, Walgreens Hit Hard By Online Pharmacy Trend
July 01, 2024
Rite Aid's restructuring plan, approved by a U.S. bankruptcy judge, reduces $2 billion in debt and shifts control to lenders. Following Chapter 11 bankruptcy and $750 million in losses, the pharmacy...
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Walgreens Plans 'Significant' Store Closures As It Faces 'Difficult Operating Environment'
June 27, 2024
Major US pharma chain Walgreens to close undisclosed number of stores due to headwinds, CEO acknowledges challenges. Rite Aid also faces bankruptcy.
Via
Benzinga
Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
June 25, 2024
MedImpact's bid to reclaim $200 million after acquiring Rite Aid's pharmacy benefits unit has failed. U.S. Bankruptcy Judge ruled MedImpact assumed Elixir's debts in the $575 million deal.
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
March 27, 2024
Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters reports. Attorney Aparna Yenamandra highlights broad stakeholder agreement,...
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Short-Sell Candidates: 3 Vastly Overvalued Stocks Ripe for Shorting
December 19, 2023
After stocks rallied, many stocks became overvalued, creating an opportunity for investors to profit through short selling.
Via
InvestorPlace
Privacy Risks Flagged: Major Pharmacy Chains Share Customer Data With Authorities Without Warrant
December 13, 2023
A congressional review of some major pharmacy chains' privacy practices found that none require a warrant before sharing customers' records with law enforcement.
Via
Benzinga
Drugstore Chain Rite Aid Counters DOJ Lawsuit Amid Bankruptcy, Aiming To Safeguard Restructuring
November 17, 2023
Rite Aid Corp (OTC: RADCQ), currently undergoing bankruptcy proceedings, has reportedly taken a legal stance against the U.S.
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
November 15, 2023
Amazon.Com, Inc. (NASDAQ: AMZN) has received a
Via
Benzinga
Exposures
Product Safety
7 Blue-Chip Stocks to Sell and Never Buy Back
November 10, 2023
Investors would be smart to part ways with these troubled blue-chip stocks to sell, each of which has seen its share price erode.
Via
InvestorPlace
WeBroke: Investors Must Avoid WE Stock if It Trades Again
November 07, 2023
WeWork just filed for bankruptcy. If WE stock starts trading again, investors should stay away at all costs.
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
October 30, 2023
Workers at pharmacy companies CVS, Walgreens and RiteAid have staged a three-day strike over unsafe and poor working conditions.
Via
InvestorPlace
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
October 30, 2023
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19...
Via
Benzinga
Exposures
COVID-19
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
October 30, 2023
Beginning Monday, pharmacy employees from leading chains such as CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and Rite Aid Corp (OTC:
Via
Benzinga
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
October 30, 2023
On Friday, the FDA issued a warning to consumers, cautioning them against the use of certain over-the-coun
Via
Benzinga
Exposures
Product Safety
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
The U.S.
Via
Benzinga
Exposures
Product Safety
3 High-Yield Stocks for Long-Term Income
October 26, 2023
These three high-yield stocks are enticing picks for income investors looking for safety and long-term growth.
Via
InvestorPlace
WBA Stock Jumps On Upgrade, Target Hike. New CEO, 'New Era' Analyst Says
October 23, 2023
JPMorgan expects Walgreens' new CEO to usher in "a new era" for the Dow Jones giant.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Make Rite Aid a Meme Stock at Your Own Risk
October 19, 2023
After declaring bankruptcy, Rite Aid has surged on meme stock momentum. Here's why that still doesn't make it a buy.
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Walgreens Agrees To Pay $192.5M To Resolve Rite Aid Buyout Suit: Report
October 19, 2023
Walgreens Boots Alliance Inc (NASDAQ: WBA) has reportedly consented to a settlement of $192.5 million following allegations that some of the company's executives provided misleading information...
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.